Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Gefitinib (Iressa) trials in non-small cell lung cancer
David H. Johnson
Int Med - Chairman's Office
Internal Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
37
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Gefitinib (Iressa) trials in non-small cell lung cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Gefitinib
100%
Non-Small Cell Lung Carcinoma
71%
Drug Therapy
18%
anilinoquinazoline
14%
Lung Neoplasms
12%
Acne Vulgaris
8%
Survival
8%
Platinum
8%
Exanthema
7%
ErbB Receptors
7%
Protein-Tyrosine Kinases
7%
In Vitro Techniques
6%
Diarrhea
6%